Index by author

March 01, 2025; Volume 92,Issue 3

  1. Katyal, Anup

    1. Insomnia in older adults
      Anup Katyal, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 143-144; DOI: https://doi.org/10.3949/ccjm.92c.03004

  2. King, Franklin

    1. Psychedelic-assisted therapy: An overview for the internist
      Brian S. Barnett, MD, Erin E. Mauney, MD and Franklin King, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 171-180; DOI: https://doi.org/10.3949/ccjm.92a.24032

      The authors review the potential effects, risks, and therapeutic applications of the psychedelic drugs MDMA (Ecstasy) and psilocybin, with a focus on MDMA-assisted therapy for posttraumatic stress disorder and psilocybin-assisted therapy for depression.

  3. Lang, David M.

    1. Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
      Nicholas B. Cline, MD, Amudha Pazhanisamy, DO and David M. Lang, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 147-151; DOI: https://doi.org/10.3949/ccjm.92a.24054

      There is no cross-reactivity between antimicrobial and nonantimicrobial sulfonamides, and patients with a history of immunoglobulin E–mediated reaction to a sulfonamide antibiotic can receive nonantimicrobial sulfonamides.

  4. Leon-barriera, Roberto

    1. In Reply: Insomnia in older adults
      Margaret M. Chaplain, MD, Roberto León-Barriera, MD and Vania Modesto-Lowe, MD, MPH
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 144; DOI: https://doi.org/10.3949/ccjm.92c.03005

  5. Madariaga, Hector

    1. Effective but inaccessible antiobesity medications
      Sima Saberi, MD, Sabiha M. Hussain, MD, Mohammad Kazem Fallahzadeh, MD, MAS, Hector Madariaga, MD, Pooja Budhiraja, MBBS and Kenneth J. Woodside, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 141; DOI: https://doi.org/10.3949/ccjm.92c.03001

  6. Mandell, Brian F.

    1. All sulfa drugs are not created equal
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 136-137; DOI: https://doi.org/10.3949/ccjm.92b.03025

      Misinformation about “sulfa allergy” can result in unnecessary avoidance of useful medications and the prescription of less effective alternatives.

  7. Mauney, Erin E.

    1. Psychedelic-assisted therapy: An overview for the internist
      Brian S. Barnett, MD, Erin E. Mauney, MD and Franklin King, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 171-180; DOI: https://doi.org/10.3949/ccjm.92a.24032

      The authors review the potential effects, risks, and therapeutic applications of the psychedelic drugs MDMA (Ecstasy) and psilocybin, with a focus on MDMA-assisted therapy for posttraumatic stress disorder and psilocybin-assisted therapy for depression.

  8. Mehta, Adi E.

    1. In Reply: Classic diabetic ketoacidosis and the euglycemic variant
      Adi E. Mehta, MD and Robert Zimmerman, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 142-143; DOI: https://doi.org/10.3949/ccjm.92c.03003

  9. Modesto-lowe, Vania

    1. In Reply: Insomnia in older adults
      Margaret M. Chaplain, MD, Roberto León-Barriera, MD and Vania Modesto-Lowe, MD, MPH
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 144; DOI: https://doi.org/10.3949/ccjm.92c.03005

  10. Morey-vargas, Oscar L.

    1. Hyperglycemic crises in adults: A look at the 2024 consensus report
      CME article
      Paloma Rodriguez Alvarez, MD, Vicente T. San Martin, MD and Oscar L. Morey-Vargas, MD
      Cleveland Clinic Journal of Medicine March 2025, 92 (3) 152-158; DOI: https://doi.org/10.3949/ccjm.92a.24089

      A new report introduces revised criteria for the diagnosis of diabetic ketoacidosis and hyperglycemic hyperosmolar state, as well as new recommendations for assessment, management, and prevention of these disorders.

« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue